{"id":765390,"date":"2023-06-22T08:07:00","date_gmt":"2023-06-22T12:07:00","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lunaphore-to-get-acquired-by-bio-techne\/"},"modified":"2023-06-22T08:07:00","modified_gmt":"2023-06-22T12:07:00","slug":"lunaphore-to-get-acquired-by-bio-techne","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lunaphore-to-get-acquired-by-bio-techne\/","title":{"rendered":"Lunaphore to Get Acquired by Bio-Techne"},"content":{"rendered":"

<\/p>\n

Lunaphore to Get Acquired by Bio-Techne<\/b><\/p>\n

TOLOCHENAZ, Switzerland & MINNEAPOLIS–(BUSINESS WIRE<\/a>)–Lunaphore Technologies SA<\/a>, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced it has reached an agreement to be acquired by Bio-Techne Corporation<\/a> (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. The acquisition is anticipated to close in Q3.\n<\/p>\n

This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20230622993410\/en\/<\/a><\/p>\n

\"(Photo:<\/p>\n

(Photo: Lunaphore)<\/p>\n<\/div>\n

\nFounded in 2014 and headquartered in Tolochenaz, Switzerland, Lunaphore is a leading developer of fully automated spatial biology solutions using precision microfluidic technology capable of revealing hyperplex proteomic and transcriptomic biomarkers in tumors and other tissues at single-cell and subcellular resolution. Providing ultimate flexibility in panel design, Lunaphore\u2019s technology and instrumentation empower researchers in immunology, immune-oncology, and neuroscience to push the boundaries of scientific discovery and accelerate therapeutic development. Lunaphore\u2019s spatial biology technology enables the identification of biomarker \u201csignatures\u201d with clinical relevance, providing data necessary to support the development of diagnostic tools and streamline clinical trials, and ultimately improve patient outcomes.\n<\/p>\n

\nLunaphore\u2019s instrument portfolio includes COMET\u2122, an end-to-end spatial biology platform, with staining, imaging, and image preprocessing steps integrated into a fully automated, high-throughput instrument, that delivers true walk-away automation with unmatched scalability, reproducibility, and tissue morphology. Eliminating the need to conjugate antibodies, researchers can leverage their existing antibody libraries and decades of know-how on Lunaphore\u2019s platforms to scale assays into endless multiplexing possibilities. Designed for use with standard pathology slides, COMET\u2122\u2019s superior tissue profiling capabilities enable the analysis of 40 different spatial biomarkers per sample in each automated run, allowing for virtually unlimited plex. The product portfolio is complemented by SPYRE\u2122 antibody panel kits and HORIZON\u2122 image analysis software. Lunaphore also offers LabSat\u00ae, an automated tissue staining instrument that offers a 30-minute turn-around time, delivering a much faster and hands-off staining solution compared to manual methods where turnaround times can take several days.\n<\/p>\n

\nBio-Techne and Lunaphore recently announced a strategic partnership to develop the first fully automated spatial multiomic workflow. This fully automated multiomics solution will utilize Lunaphore\u2019s COMET\u2122 instrument and SPYRE\u2122 antibody panels as well as Bio-Techne\u2019s RNAscope HiPlex technology to enable simultaneous hyperplex detection of protein and RNA biomarkers on the same slide at single-cell resolution.\n<\/p>\n

\n\u201cLunaphore is very complementary to Bio-Techne\u2019s leading spatial biology franchise, as COMET\u2122 delivers an automation platform for our RNAscope assays, and we leverage our global commercial team to penetrate this rapidly growing market. We also see additional synergies with our leading portfolio of antibodies and other products,\u201d said Chuck Kummeth, President and Chief Executive Officer of Bio-Techne. \u201cLunaphore is seeing strong initial traction with its COMET\u2122 instrument, as this fully integrated, fully automated spatial biology system delivers the end-to-end automation that is in high demand from translational researchers. We anticipate COMET\u2122 to play an important role as spatial biology gains traction in clinical applications. We are excited to welcome Lunaphore\u2019s talented team, instrument portfolio, and technology to Bio-Techne.\u201d\n<\/p>\n

\n\u201cWe are truly excited to be joining Bio-Techne and combining capabilities to lead the Spatial Biology market.\u201d said Dr. Ata Tuna Ciftlik, Chief Executive Officer of Lunaphore. \u201cOur shared vision of tackling the translational and clinical research market, while using our complementary best-in-class spatial proteomics and transcriptomics products is going to make a great impact on our customers in advancing research. In addition, Bio-Techne\u2019s global reach, and commercial and operational excellence will enable Lunaphore to accelerate its penetration into the high growth spatial biology market. We\u2019re now joining forces to be the largest spatial biology player.\u201d\n<\/p>\n

\nWenger Plattner is serving as Bio-Techne\u2019s legal counsel. Bourgeois Avocats SA is serving as legal counsel to Lunaphore. UBS Investment Bank served as financial advisor to Lunaphore.\n<\/p>\n

\nForward Looking Statements:\n<\/p>\n

\nOur press releases may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Such statements involve risks and uncertainties that may affect the actual results of operations. Forward looking statements in this press release include statements regarding our belief about the market applications and impact of our pending acquisition of Lunaphore, Inc. and our ability to derive advantages from this acquisition as we integrate it into our business. The following important factors, among others, have affected and, in the future, could affect the Company’s actual results: the effect of new branding and marketing initiatives, the integration of new businesses and leadership, the introduction and acceptance of new products, the funding and focus of the types of research by the Company’s customers, the impact of the growing number of producers of biotechnology research products and related price competition, general economic conditions, customer site closures or supply chain issues resulting from the COVID-19 pandemic, the impact of currency exchange rate fluctuations, and the costs and results of research and product development efforts of the Company and of companies in which the Company has invested or with which it has formed strategic relationships.\n<\/p>\n

\nFor additional information concerning such factors, see the section titled “Risk Factors” in the Company’s annual report on Form 10-K and quarterly reports on Form 10-Q as filed with the Securities and Exchange Commission. We undertake no obligation to update or revise any forward-looking statements we make in our press releases due to new information or future events. Investors are cautioned not to place undue emphasis on these statements.\n<\/p>\n

About Bio-Techne Corporation<\/a> (NASDAQ: TECH)\n<\/p>\n

About Lunaphore<\/a><\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20230622993410\/en\/<\/a><\/span><\/p>\n

\nBio-Techne Corporation:
\n
David Clair, Vice President, Investor Relations and Corporate Development
\n
david.clair@bio-techne.com
\n<\/a>
612-656-4416\n<\/p>\n

\nLunaphore
\n
D\u00e9borah Heintze, Chief Marketing Officer
\n
deborah.heintze@lunaphore.com<\/a><\/p>\n

KEYWORDS:<\/b> Europe Switzerland United States North America Minnesota<\/p>\n

INDUSTRY KEYWORDS:<\/b> Research Medical Devices Clinical Trials Other Health Biotechnology General Health Health Science Oncology Other Science<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n\n\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n
Photo<\/b><\/font><\/td>\n<\/tr>\n
\"Photo\"<\/td>\n<\/tr>\n
(Photo: Lunaphore)<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Lunaphore to Get Acquired by Bio-Techne TOLOCHENAZ, Switzerland & MINNEAPOLIS–(BUSINESS WIRE)–Lunaphore Technologies SA, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced it has reached an agreement to be acquired by Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. The acquisition is anticipated to close in Q3. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20230622993410\/en\/ (Photo: Lunaphore) Founded in 2014 and headquartered in Tolochenaz, Switzerland, Lunaphore is a leading developer of fully automated spatial biology solutions using precision microfluidic technology capable of revealing hyperplex proteomic and transcriptomic biomarkers in tumors and other tissues at single-cell and subcellular … <\/p>\n

Continue reading “Lunaphore to Get Acquired by Bio-Techne”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-765390","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nLunaphore to Get Acquired by Bio-Techne - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lunaphore-to-get-acquired-by-bio-techne\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lunaphore to Get Acquired by Bio-Techne - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Lunaphore to Get Acquired by Bio-Techne TOLOCHENAZ, Switzerland & MINNEAPOLIS–(BUSINESS WIRE)–Lunaphore Technologies SA, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced it has reached an agreement to be acquired by Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. The acquisition is anticipated to close in Q3. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20230622993410\/en\/ (Photo: Lunaphore) Founded in 2014 and headquartered in Tolochenaz, Switzerland, Lunaphore is a leading developer of fully automated spatial biology solutions using precision microfluidic technology capable of revealing hyperplex proteomic and transcriptomic biomarkers in tumors and other tissues at single-cell and subcellular … Continue reading "Lunaphore to Get Acquired by Bio-Techne"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lunaphore-to-get-acquired-by-bio-techne\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-22T12:07:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230622993410\/en\/1825967\/4\/LB_press_release.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lunaphore-to-get-acquired-by-bio-techne\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lunaphore-to-get-acquired-by-bio-techne\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lunaphore to Get Acquired by Bio-Techne\",\"datePublished\":\"2023-06-22T12:07:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lunaphore-to-get-acquired-by-bio-techne\\\/\"},\"wordCount\":990,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lunaphore-to-get-acquired-by-bio-techne\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230622993410\\\/en\\\/1825967\\\/4\\\/LB_press_release.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lunaphore-to-get-acquired-by-bio-techne\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lunaphore-to-get-acquired-by-bio-techne\\\/\",\"name\":\"Lunaphore to Get Acquired by Bio-Techne - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lunaphore-to-get-acquired-by-bio-techne\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lunaphore-to-get-acquired-by-bio-techne\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230622993410\\\/en\\\/1825967\\\/4\\\/LB_press_release.jpg\",\"datePublished\":\"2023-06-22T12:07:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lunaphore-to-get-acquired-by-bio-techne\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lunaphore-to-get-acquired-by-bio-techne\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lunaphore-to-get-acquired-by-bio-techne\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230622993410\\\/en\\\/1825967\\\/4\\\/LB_press_release.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230622993410\\\/en\\\/1825967\\\/4\\\/LB_press_release.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lunaphore-to-get-acquired-by-bio-techne\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lunaphore to Get Acquired by Bio-Techne\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lunaphore to Get Acquired by Bio-Techne - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lunaphore-to-get-acquired-by-bio-techne\/","og_locale":"en_US","og_type":"article","og_title":"Lunaphore to Get Acquired by Bio-Techne - Market Newsdesk","og_description":"Lunaphore to Get Acquired by Bio-Techne TOLOCHENAZ, Switzerland & MINNEAPOLIS–(BUSINESS WIRE)–Lunaphore Technologies SA, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced it has reached an agreement to be acquired by Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. The acquisition is anticipated to close in Q3. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20230622993410\/en\/ (Photo: Lunaphore) Founded in 2014 and headquartered in Tolochenaz, Switzerland, Lunaphore is a leading developer of fully automated spatial biology solutions using precision microfluidic technology capable of revealing hyperplex proteomic and transcriptomic biomarkers in tumors and other tissues at single-cell and subcellular … Continue reading \"Lunaphore to Get Acquired by Bio-Techne\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lunaphore-to-get-acquired-by-bio-techne\/","og_site_name":"Market Newsdesk","article_published_time":"2023-06-22T12:07:00+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230622993410\/en\/1825967\/4\/LB_press_release.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lunaphore-to-get-acquired-by-bio-techne\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lunaphore-to-get-acquired-by-bio-techne\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lunaphore to Get Acquired by Bio-Techne","datePublished":"2023-06-22T12:07:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lunaphore-to-get-acquired-by-bio-techne\/"},"wordCount":990,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lunaphore-to-get-acquired-by-bio-techne\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230622993410\/en\/1825967\/4\/LB_press_release.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lunaphore-to-get-acquired-by-bio-techne\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lunaphore-to-get-acquired-by-bio-techne\/","name":"Lunaphore to Get Acquired by Bio-Techne - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lunaphore-to-get-acquired-by-bio-techne\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lunaphore-to-get-acquired-by-bio-techne\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230622993410\/en\/1825967\/4\/LB_press_release.jpg","datePublished":"2023-06-22T12:07:00+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lunaphore-to-get-acquired-by-bio-techne\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lunaphore-to-get-acquired-by-bio-techne\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lunaphore-to-get-acquired-by-bio-techne\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230622993410\/en\/1825967\/4\/LB_press_release.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230622993410\/en\/1825967\/4\/LB_press_release.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lunaphore-to-get-acquired-by-bio-techne\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lunaphore to Get Acquired by Bio-Techne"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/765390","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=765390"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/765390\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=765390"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=765390"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=765390"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}